Quantitative Structure Activity Relationship Studies of Piperazinyl Phenylalanine Derivatives as VLA-4/VCAM-1 Inhibitors

被引:3
作者
Bhargava, Dinesh [1 ]
Karthikeyan, C. [1 ]
Moorthy, N. S. H. N. [1 ]
Trivedi, Piyush [1 ]
机构
[1] Rajiv Gandhi Proudyogiki Vishwavidyalaya, Sch Pharmaceut Sci, Bhopal 462036, Madhya Pradesh, India
关键词
QSAR; Piperazinyl phenylalanine; V-life; VLA-4/VCAM-1; MONOCLONAL-ANTIBODY; INTEGRIN;
D O I
10.2174/157340609789117822
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
QSAR study was carried out for a series of piperazinyl phenylalanine derivatives exhibiting VLA-4/VCAM-1 inhibitory activity to find out the structural features responsible for the biological activity. The QSAR study was carried out on V-life Molecular Design Suite software and the derived best QSAR model by partial least square (forward) regression method showed 85.67% variation in biological activity. The statistically significant model with high correlation coefficient (r(2) = 0.85) was selected for further study and the resulted validation parameters of the model, cross validated correlation coefficient (q(2) = 0.76 and pred_r(2) = 0.42) show the model has good predictive ability. The model showed that the parameters SaaNEindex, SsClcount SlogP, and 4PathCount are highly correlated with VLA-4/VCAM-1 inhibitory activity of piperazinyl phenylalanine derivatives. The result of the study suggests that the chlorine atoms in the molecule and fourth order fragmentation patterns in the molecular skeleton favour VLA-4/VCAM-1 inhibition shown by the title compounds whereas lipophilicity and nitrogen bonded to aromatic bond are not conducive for VLA-4/VCAM-1 inhibitory activity.
引用
收藏
页码:446 / 454
页数:9
相关论文
共 11 条
[1]   A small-molecule, tight-binding inhibitor of the integrin α4β1 blocks antigen-induced airway responses and inflammation in experimental asthma in sheep [J].
Abraham, WM ;
Gill, A ;
Ahmed, A ;
Sielczak, MW ;
Lauredo, IT ;
Botinnikova, Y ;
Lin, KC ;
Pepinsky, B ;
Leone, DR ;
Lobb, RR ;
Adams, SP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (02) :603-611
[2]  
GEORGE AD, 2002, BIOORG MED CHEM LETT, V12, P729
[3]   Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritis [J].
Ianaro, A ;
Cicala, C ;
Calignano, A ;
Koteliansky, V ;
Gotwals, P ;
Bucci, M ;
Gerli, R ;
Santucci, L ;
Fiorucci, S ;
Cirino, G .
LABORATORY INVESTIGATION, 2000, 80 (01) :73-80
[4]   Evidence for a prolonged role of alpha(4) integrin throughout active experimental allergic encephalomyelitis [J].
Keszthelyi, E ;
Karlik, S ;
Hyduk, S ;
Rice, GPA ;
Gordon, G ;
Yednock, T ;
Horner, H .
NEUROLOGY, 1996, 47 (04) :1053-1059
[5]  
MARIEAGNE S, 2007, MED CHEM LETT, V17, P142
[6]  
MILLER B, 2008, OPENSTAT SOFTWARE VE
[7]   A controlled trial of natalizumab for relapsing multiple sclerosis. [J].
Miller, DH ;
Khan, OA ;
Sheremata, WA ;
Blumhardt, LD ;
Rice, GPA ;
Libonati, MA ;
Willmer-Hulme, AJ ;
Dalton, CM ;
Miszkiel, KA ;
O'Connor, PW .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01) :15-23
[8]  
OSAMU S, 2008, BIOORG MED CHEM LETT, V18, P1053
[9]   ATTENUATION OF COLITIS IN THE COTTON-TOP TAMARIN BY ANTI-ALPHA-4 INTEGRIN MONOCLONAL-ANTIBODY [J].
PODOLSKY, DK ;
LOBB, R ;
KING, N ;
BENJAMIN, CD ;
PEPINSKY, B ;
SEHGAL, P ;
DEBEAUMONT, M .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) :372-380
[10]   ANTIBODY TO VERY LATE ACTIVATION ANTIGEN-4 PREVENTS ANTIGEN-INDUCED BRONCHIAL HYPERREACTIVITY AND CELLULAR INFILTRATION IN THE GUINEA-PIG AIRWAYS [J].
PRETOLANI, M ;
RUFFIE, C ;
SILVA, JRLE ;
JOSEPH, D ;
LOBB, RR ;
VARGAFTIG, BB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) :795-805